Citadel Advisors’s SPDR S&P International Health Care Sector IRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,348
Closed -$204K 8659
2017
Q1
$204K Buy
+4,348
New +$198K ﹤0.01% 6497
2016
Q4
Sell
-38,027
Closed -$1.81M 8423
2016
Q3
$1.81M Buy
38,027
+33,700
+779% +$1.64M ﹤0.01% 3088
2016
Q2
$210K Buy
+4,327
New +$207K ﹤0.01% 5771
2016
Q1
Sell
-32,942
Closed -$1.66M 9301
2015
Q4
$1.66M Buy
32,942
+5,866
+22% +$291K ﹤0.01% 2961
2015
Q3
$1.31M Buy
+27,076
New +$1.42M ﹤0.01% 3467

Other funds holding IRY

Citadel Advisors's IRY Position: Q2 2017 in Review

Citadel Advisors sold out of SPDR S&P International Health Care Sector (IRY) in Q2 2017, closing a stake of 4,348 shares — an estimated $204K sold.

Citadel Advisors first reported a position in IRY in Q3 2015 and held it in 5 quarters. The position peaked at $1.81M in Q3 2016. 26 funds tracked by Wall St. Rank hold IRY as of Q2 2017.

  • Citadel Advisors reported no remaining SPDR S&P International Health Care Sector position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 4,348 SPDR S&P International Health Care Sector shares in Q2 2017, an estimated $204K.
  • Citadel Advisors first reported a position in SPDR S&P International Health Care Sector in Q3 2015 and held it in 5 quarters.
  • Citadel Advisors's SPDR S&P International Health Care Sector position peaked at $1.81M in Q3 2016.
  • 26 funds tracked by Wall St. Rank held SPDR S&P International Health Care Sector as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.